Instil Bio, Inc. Shareholders' Equity
Instil Bio, Inc. (TIL) had Shareholders' Equity of $107.38 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $107.38M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $110.70M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $113.87M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $120.42M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $107.38M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $110.70M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $113.87M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $120.42M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $131.67M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $144.91M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $169.44M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $176.33M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $195.02M 10-Q · filed 2025-11-13 |
| 2024-03-31 | $205.83M 10-Q · filed 2025-11-13 |
| 2023-12-31 | $225.83M 10-K · filed 2026-03-27 |
| 2023-09-30 | $234.02M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $296.52M 10-Q · filed 2024-11-13 |
| 2023-03-31 | $311.15M 10-Q · filed 2024-11-13 |
| 2022-12-31 | $363.61M 10-K · filed 2025-03-04 |
| 2022-09-30 | $410.59M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $458.33M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $508.56M 10-Q · filed 2023-11-13 |
| 2021-12-31 | $555.20M 10-K · filed 2024-03-21 |
| 2021-09-30 | $601.42M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $635.47M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $665.15M 10-Q · filed 2022-11-14 |
| 2020-12-31 | -$39.60M 10-K · filed 2023-03-31 |
| 2020-09-30 | -$22.82M 10-Q · filed 2021-11-15 |
| 2020-06-30 | -$16.00M 10-Q · filed 2021-11-15 |
| 2020-03-31 | -$7.71M 10-Q · filed 2021-11-15 |
| 2019-12-31 | -$6.89M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |